CClinicalTrials.gg
CompletedNCT022330883ELMUpdated Jan 12, 2023

A Pilot Study of a Lifestyle Intervention on the Metabolic Syndrome (3ELM Study)

An interventional study of ELM Group and ELM Classes in Metabolic Syndrome, sponsored by Rush University Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years to 72 Years. Per ClinicalTrials.gov, last updated 2023-01-12.

Sponsored by Rush University Medical Center · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Sep 2013, registered Aug 2014).
Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
18 Years to 72 Years
Sex
All
01

Study summary

Approximately 24% of the US adult population meet criteria for metabolic syndrome (MetS), diagnosed by a combination of abdominal obesity, elevated blood pressure, high triglyceride and low HDL-cholesterol level, and pre-diabetes. MetS quintuples the risk of diabetes, and doubles the risk of cardiovascular disease (CVD), particularly heart failure. Lifestyle modification is the initial step of treatment, but few studies have demonstrated early and sustained efficacy in remission of MetS. Our preliminary studies of a lifestyle change program for patients with MetS included a 1-year of development of an intervention by an interdisciplinary team of experts in medicine and the behavioral sciences. The investigators then tested the efficacy of the intervention in a treatment-only, proof-of-concept study. The investigators achieved our goal of 50% MetS remission after 2 years, in a sample of 26 patients. This study is the second step of a research program testing an innovative bio-behavioral intervention aimed at remitting MetS through lifestyle intervention, by focusing on eating patterns, daily activity, and stress management. The overarching objective of this research program is to determine the efficacy of the ELM lifestyle intervention to achieve remission of MetS. This purpose of the current study is to prepare for a large, randomized, clinical trial by conducting a smaller clinical trial that examines the acceptability of the ELM intervention (ELM Group) as compared to two other intervention arms (ELM Classes, ELM Individual).

Read the detailed description

The 3ELM ("Eat, Love, Move") study recruits 48 patients with MetS, and provides a 6-month intervention that aims to remit MetS by promoting the long-term adoption of healthier behaviors (diet, physical activity, stress reduction). Participants in 3ELM are randomly assigned to one of the study arms ("ELM Groups", "ELM Classes", "ELM Individual"); all of which receive some type of intervention in either group, class, or individual formats. The primary aim of this project is to pilot test the acceptability of each of the study arms and the outcome measures.

The study also includes outcome assessments at 3 time points: at the start of the study, and at 3, and 6 months post baseline. All study participants will receive medical care (including metabolic syndrome care) from their regular medical doctors. Study staff will track participants' use of health care and wellness services during the study after obtaining participant permission to collect this data.

02

Conditions studied

  • Metabolic Syndrome

Keywords

  • Prediabetic State
  • Hypertension
  • Enlarged Waist Elevated Triglycerides
  • HDL Cholesterol, Low Serum
03

In context

Metabolic Syndrome

1,964 studies on the registry are indexed under Metabolic Syndrome; 330 are open to participants now.

This study's enrollment of 48 is below the median of 60 across 1,460 interventional studies indexed under Metabolic Syndrome.

Browse Metabolic Syndrome studies →

Lead sponsor

Rush University Medical Center is the lead sponsor of 394 studies on the registry; 61 are open to participants now.

Of its 30 completed or terminated interventional studies of FDA-regulated products, 25 (83%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 72 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Men and women age 18-72 years (children and the elderly need age-specific lifestyle tailoring).
  • Able to walk 2 blocks (the patients should be able to engage in moderate intensity exercise).
  • Have preference for making lifestyle changes to treat MetS.
  • Able to participate in a lifestyle intervention for 6 months.
  • Meet at least 3 Metabolic syndrome criteria: abdominal obesity (waist girth >102♂/88♀ cm), high blood pressure (≥130/85 mm Hg or treatment), triglyceridemia (≥150 mg/dL or fibrate therapy), low HDL-cholesterol (\<40♂/50♀ mg/dL or niacin therapy) or fasting glucose ≥100 mg/dL (or pre-diabetes).

Exclusion criteria

Exclusion Criteria:

  • Substance abuse within the past 12 months: alcohol use, current daily smokers (self-report); and illicit drug use.
  • Weight loss, exceeding 10% of initial weight, in the past 6 months or current use of medications for weight loss, bowel resection surgery, bariatric surgery, eating disorder.
  • Other medical or behavioral limitations judged to interfere with study participation or the ability to follow study procedures (eg, scheduled surgery, travel plans or scheduling difficulties that do not permit full participation), limited English language, cognitive impairment, pregnancy, or psychiatric comorbidities (such as severe major depression, or psychotic disorders).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
48 participants (actual)

Study arms

  • Experimental
    ELM Group

    A 6-month group lifestyle intervention, consisting of 12 weekly and 6 bi-weekly 2-hour sessions. The sessions consist of 30-min physical activity, 30-min meal demonstration, and 60-min group behavioral intervention, with a focus on experiential learning in naturalistic setting. Sessions are facilitated by dietitian/personal trainer and behavioral specialist.

    Behavioral: ELM Group

  • Other
    ELM Classes

    A 6-month health education, consisting of 12 weekly and 6 bi-weekly 30-45 min sessions. The sessions consist of didactic classes, with a focus on health education curriculum. Sessions are facilitated by a health educator and medical providers.

    Other: ELM Classes

  • Active comparator
    ELM Individual

    A 6-month intervention, that consists of educational manuals on physical activity, diet and stress reduction and recommended 3 medical visits every 3 months for medical counseling and feedback using 5A (Ask, Advise, Assess, Assist, and Arrange) framework . These Metabolic syndrome care materials and provider documentation will be embedded in electronic medical record system, and will be accessible to medical providers by usual means. This enhanced usual care by participant's usual health care provider focuses on metabolic syndrome and lifestyle modifications to reduce the risk of chronic disease.

    Other: ELM Individual

Interventions

  • BehavioralELM Group

    ELM participants are trained to portion their meals according to the "Perfect Plate" method, a modified version of the USDA's ChooseMyPlate.gov. The stress management focuses on mindful living, cognitive restructuring; the enhancement of positive emotions. The physical activity component focuses on reduction of sedentary activity (by increasing daily step counts) and moderate-to-vigorous physical activity.

    Also known as: ELM Lifestyle Intervention

  • OtherELM Classes

    ELM classes will be administered through Rush Generations program and focus on health education.

    Also known as: Health Education

  • OtherELM Individual

    ELM Individual arm participants will receive education materials on metabolic syndrome and diet, exercise, stress reduction recommendations. The participants will be recommended to follow these guidelines and discuss/seek support from their health care provider (visits at baseline, 3 and 6 months will be recommended.

06

What researchers measure

Primary outcomes

  1. metabolic syndrome remission, defined as <3 of the 5 standard diagnostic criteria.

    metabolic syndrome remission will be assessed by measurement of waist girth, blood pressure, fasting serum lipid and glucose levels, and the number of medications to treat blood pressure.

    Time frame: 6-month change

Secondary outcomes

  1. Nutrition intake

    Healthy Eating Index (HEI-2010) will be computed using data from 24-h dietary recalls, conducted on nonconsecutive days, including one weekend day, using the Nutrition Data System for Research (NDSR).128 The HEI-2010 is a quantifiable method of assessing the adherence to Dietary Guidelines for Americans.

    Time frame: Baseline, and 6 months

  2. Accelerometry

    Accelerometry (Actigraph) is the gold standard objective method for daily activity data collection. Standard methods for equipment programming and data reduction, supplemented by activity and sleep log will be used to calculate minutes/week of moderate/vigorous activity, sedentary activity, sleep, and accelerometer step counts.

    Time frame: At baseline and 6 months

  3. International Physical Activity Questionnaire (IPAQ)

    Measures engagement in physical activity

    Time frame: At baseline and 6 months

  4. Perceived Stress Scale

    a 10-item questionnaire that measures stress

    Time frame: At baseline, 3, and 6 months

  5. Weight

    Weight will be measured using stationary scale per standardized protocol.

    Time frame: At baseline, 3, and 6 months

  6. A1c

    A plasma sample will be collected to measure HbA1c.

    Time frame: At baseline and 6 months

  7. Credibility and expectancies questionnaire (CEQ)

    A 4-item questionnaire measures participants acceptability ratings - specifically whether they think the treatments are credible and if they think they will help them with their health goals.

    Time frame: At baseline, 3, and 6 months

  8. Vitality Index

    will be tracked using a 4 item subscale of Medical Outcomes Study (MOS) 36-Item Short Form Health survey that measures perceived energy and fatigue within the last 30 days.

    Time frame: At baseline, 3, and 6 months

  9. Continuous metabolic syndrome score

    calculated as a sum of z-scores of the individual 5 MetS components using reported methodology from other clinical trials. This MetS research tool has methodological advantage accounting for severity of MetS.

    Time frame: At baseline, 3, and 6 months

Other outcomes

  1. Medication questionnaire

    The list of medications with dose and frequency of administration will be collected using a standardized questionnaire.

    Time frame: At baseline, 3, and 6 months

  2. Brief COPE

    measures coping of stressors

    Time frame: At baseline, and 6 months

  3. Daily Hassles Questionnaire

    measures primary and secondary appraisal of stressors.

    Time frame: At baseline, 3, and 6 months

  4. Three Factor Eating Questionnaire (TFEQ)

    Measures disordered eating patterns.

    Time frame: At baseline, and 6 months

  5. Patient Health Questionnaire (PHQ-9)

    Measures depressive symptoms

    Time frame: At baseline, 3, and 6 months

  6. Treatment Self-Regulation Questionnaire (TSRQ for eating and physical activity)

    Measures self-regulation abilities for eating and physical activity

    Time frame: At baseline, 3, and 6 months

  7. Work Productivity and Activity Impairment Questionnaire

    measures lost productivity in the form of absenteeism and presenteeism.

    Time frame: At baseline, 3, and 6 months

  8. Use of wellness, health, and preventive services

    Wil be used for cost analysis.

    Time frame: At baseline, 3, and 6 months

  9. Perceived environment (food and exercise)

    measures the built and food environment

    Time frame: At baseline

  10. Global health scale

    Self-assessment of overall health.

    Time frame: At baseline, 3, and 6 months

  11. General Questionnaire

    Measures basic sociodemographic characteristics.

    Time frame: At baseline, updated at 3, and 6 months

  12. Weight history and experiences with wellness/weight management programs

    Captures weight fluctuations and participation in commercial or health care based wellness or weight loss programs

    Time frame: At baseline, and updated at 3 and 6 months

  13. Treatment modality preferences and willingness

    Captures participant preferences for lifestyle, medication, and surgical treatment modalities.

    Time frame: At baseline and 6 months

  14. Beliefs about medications

    Captures participant's beliefs about the usefulness and safety of medications.

    Time frame: At baseline

  15. Time horizon

    Assesses executive function

    Time frame: At baseline and 6 months

  16. Patient Reported Outcomes Measurement Information System (PROMIS) Cognition questionnaire

    measures cognitive/executive function.

    Time frame: At baseline and 6 months

  17. Perceived lifestyle change for physical activity and diet

    Captures participant's self-assessment of effort-related to lifestyle changes.

    Time frame: At 3 and 6 months

07

Study locations

1 site
  • Rush University Medical Center
    Chicago, Illinois 60612, United States
08

References and documents

Study documents

  • Protocol and informed consent form · Aug 12, 2014
  • Statistical analysis plan · Aug 28, 2013

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 12, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02233088
Lead sponsor
Rush University Medical Center
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Responsible party
Sponsor
First posted
Sep 8, 2014
Start date
Sep 20, 2013
Primary completion
Aug 31, 2015
Completion
Dec 31, 2021
Last update
Jan 12, 2023

Study contacts

Rasa Kazlauskaite, MD
principal investigator · Rush University Medical Center
Lisa Walt, PhD
study director · Rush University Medical Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion